Discovery of INT131: A selective PPARγ modulator that enhances insulin sensitivity
摘要:
PPAR gamma is a member of the nuclear hormone receptor family and plays a key role in the regulation of glucose homeostasis. This Letter describes the discovery of a novel chemical class of diarylsulfonamide partial agonists that act as selective PPAR gamma modulators (SPPAR gamma Ms) and display a unique pharmacological profile compared to the thiazolidinedione (TZD) class of PPAR gamma full agonists. Herein we report the initial discovery of partial agonist 4 and the structure-activity relationship studies that led to the selection of clinical compound INT131 (3), a potent PPAR gamma partial agonist that displays robust glucose-lowering activity in rodent models of diabetes while exhibiting a reduced side-effects profile compared to marketed TZDs. (C) 2012 Elsevier Ltd. All rights reserved.
Modulators of PPARγ activity are used in methods of treating and/or preventing conditions such as osteoporosis, Alzheimer's disease, psoriasis and acne, and cancer.
[EN] COMPOUNDS FOR THE MODULATION OF PPAR gamma ACTIVITY<br/>[FR] COMPOSES UTILISES POUR LA MODULATION DE L'ACTIVITE DE PPAR gamma
申请人:TULARIK INC
公开号:WO2001000579A1
公开(公告)日:2001-01-04
Modulators of PPARη activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity.
Modulators of PPAR&ggr; activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity.
Compounds for the modulation of PPAR&ggr; activity
申请人:Tularik Inc.
公开号:US06770648B2
公开(公告)日:2004-08-03
Modulators of PPAR&ggr; activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity.
COMPOUNDS FOR THE MODULATION OF PPARgamma ACTIVITY
申请人:McGee Lawrence R.
公开号:US20100113522A1
公开(公告)日:2010-05-06
Modulators of PPARγ activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity.